Skip to main content

Gossamer Bio, Inc.

For the period ended Mar 31, 2025. Filed May 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 15, 2025

GOSS$10.65+9.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I. FINANCIAL INFORMATION
Item 1Condensed Consolidated Financial Statements (unaudited)4
Condensed Consolidated Balance Sheets as of March 31, 2025 (unaudited) and December 31, 20244
Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three Months ended March 31, 2025 and 2024 (unaudited)5
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the Three Months ended March 31, 2025 and 2024 (unaudited)6
Condensed Consolidated Statements of Cash Flows for the Three Months ended March 31, 2025 and 2024 (unaudited)7
Notes to Unaudited Condensed Consolidated Financial Statements8
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations24
Item 3Quantitative and Qualitative Disclosures About Market Risk31
Item 4Controls and Procedures32
PART II. OTHER INFORMATION
Item 1Legal Proceedings33
Item 1ARisk Factors33
Item 2Unregistered Sales of Equity Securities and Use of Proceeds33
Item 3Defaults Upon Senior Securities33
Item 4Mine Safety Disclosures33
Item 5Other Information33
Item 6Exhibits33
Exhibit Index34
Signatures35
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.